🇺🇸 FDA
Patent

US 10995089

Zaindole derivatives and their use as ERK kinase inhibitors

granted A61KA61K31/4353A61P

Quick answer

US patent 10995089 (Zaindole derivatives and their use as ERK kinase inhibitors) held by AGV Discovery expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AGV Discovery
Grant date
Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4353, A61P, A61P35/00